TFP5 compound shows promise to reverse Alzheimer’s Disease
(Best Syndication News) - Researchers injected TFP5 molecules into mice with Alzheimer’s disease and were able to restore their memory function. The new findings were published in the January 2013 issue of the FASEB Journal.
Scientists at the National Institutes of Health injected TFP5 molecules into mice that had a disease similar to the Alzheimer’s disease in humans. To measure against a control group, other brain diseased mice were injected with a placebo. The mice that received the TFP5 molecules had their symptoms reversed and they had regained their memory while the placebo group continued to decline as expected. The TFP5 did not demonstrate any toxic side effects in the mice.
Senior researcher, Harish C. Pant, Ph.D., a scientist at the Laboratory of Neurochemistry’s National Institute of Neurological Disorders in Bethesda, Maryland, expressed hope that a clinical trial involving humans with Alzheimer’s disease will show similar results.
According the Alzheimer’s Association, around 5.4 million people in the United States have Alzheimer’s disease. The disease is ranked number six as a leading cause of death. Currently, Alzheimer’s does not have a course for prevention and cannot be cured. The researchers say other treatments haven’t slowed the progression.
By: Marsha Quinn
ref: Ref: FASEB J. January 2013 27:174-186; doi:10.1096/fj.12-217497; http://www.fasebj.org/content/27/1/174.abstract, 2.